Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Cytomegalovirus Colitis After 5‐Fluorouracil and Interferon‐α Therapy
James L. Baker
, Michael P. Gosland
, Jon D. Herrington
,
Kenneth E. Record
Pharmacy Practice and Science
Research output
:
Contribution to journal
›
Article
›
peer-review
20
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cytomegalovirus Colitis After 5‐Fluorouracil and Interferon‐α Therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Colitis
100%
Cytomegalovirus
100%
Interferon
100%
Diarrhea
66%
Cytomegalovirus Infection
66%
Drug Therapy
33%
Patient with Inflammatory Bowel Disease
33%
Virus Infection
33%
Biopsy Technique
33%
Colon
33%
Continuous Infusion
33%
Gastrointestinal Tract
33%
Immunocompromised Patient
33%
Pancreas Carcinoma
33%
Immunofluorescence
33%
Antidiarrheal Agent
33%
Ganciclovir
33%
Pharmacology, Toxicology and Pharmaceutical Science
Colitis
100%
Cytomegalovirus
100%
Interferon
100%
Diarrhea
66%
Cytomegalovirus Infection
66%
Pharmacotherapy
33%
Inflammatory Bowel Disease
33%
Antidiarrheal Agent
33%
Virus Infection
33%
Pancreas Carcinoma
33%
Immunocompromised Patient
33%
Ganciclovir
33%